Phytochemicals of Periploca aphylla Dcne. ameliorated streptozotocin-induced diabetes in rat

Abstract Background Periploca aphylla is used by local population and indigenous medicine practitioners as stomachic, tonic, antitumor, antiulcer, and for treatment of inflammatory disorders. The aim of this study was to evaluate antidiabetic effect of the extract of P. aphylla and to investigate an...

Full description

Bibliographic Details
Main Authors: Umbreen Rashid, Muhammad Rashid Khan
Format: Article
Language:English
Published: Komiyama Printing Co. Ltd 2021-03-01
Series:Environmental Health and Preventive Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12199-021-00962-0
_version_ 1818502361282248704
author Umbreen Rashid
Muhammad Rashid Khan
author_facet Umbreen Rashid
Muhammad Rashid Khan
author_sort Umbreen Rashid
collection DOAJ
description Abstract Background Periploca aphylla is used by local population and indigenous medicine practitioners as stomachic, tonic, antitumor, antiulcer, and for treatment of inflammatory disorders. The aim of this study was to evaluate antidiabetic effect of the extract of P. aphylla and to investigate antioxidant and hypolipidemic activity in streptozotocin (STZ)-induced diabetic rats. Methods The present research was conducted to evaluate the antihyperglycemic potential of methanol extract of P. aphylla (PAM) and subfractions n-hexane (PAH), chloroform (PAC), ethyl acetate (PAE), n-butanol (PAB), and aqueous (PAA) in glucose-overloaded hyperglycemic Sprague-Dawley rats. Based on the efficacy, PAB (200 mg/kg and 400 mg/kg) was tested for its antidiabetic activity in STZ-induced diabetic rats. Diabetes was induced via intraperitoneal injection of STZ (55 mg/kg) in rat. Blood glucose values were taken weekly. HPLC-DAD analysis of PAB was carried out for the presence of various polyphenols. Results HPLC-DAD analysis of PAB recorded the presence of rutin, catechin, caffeic acid, and myricetin. Oral administration of PAB at doses of 200 and 400 mg/kg for 21 days significantly restored (P < 0.01) body weight (%) and relative liver and relative kidney weight of diabetic rats. Diabetic control rats showed significant elevation (P < 0.01) of AST, ALT, ALP, LDH, total cholesterol, triglycerides, LDL, creatinine, total bilirubin, and BUN while reduced (P < 0.01) level of glucose, total protein, albumin, insulin, and HDL in serum. Count of blood cells and hematological parameters were altered in diabetic rats. Further, glutathione peroxidase, catalase, superoxide dismutase, glutathione reductase, and total soluble protein concentration decreased while concentration of thiobarbituric acid reactive substances and percent DNA damages increased (P < 0.01) in liver and renal tissues of diabetic rats. Histopathological damage scores increased in liver and kidney tissues of diabetic rats. Intake of PAB (400 mg/kg) resulted in significant improvement (P < 0.01) of above parameters, and results were comparable to that of standard drug glibenclamide. Conclusion The result suggests the antihyperglycemic, antioxidant, and anti-inflammatory activities of PAB treatment in STZ-compelled diabetic rat. PAB might be used as new therapeutic agent in diabetic patients to manage diabetes and decrease the complications.
first_indexed 2024-12-10T21:09:13Z
format Article
id doaj.art-a0eccfb9ef8a40028299374965055374
institution Directory Open Access Journal
issn 1342-078X
1347-4715
language English
last_indexed 2024-12-10T21:09:13Z
publishDate 2021-03-01
publisher Komiyama Printing Co. Ltd
record_format Article
series Environmental Health and Preventive Medicine
spelling doaj.art-a0eccfb9ef8a400282993749650553742022-12-22T01:33:32ZengKomiyama Printing Co. LtdEnvironmental Health and Preventive Medicine1342-078X1347-47152021-03-0126111410.1186/s12199-021-00962-0Phytochemicals of Periploca aphylla Dcne. ameliorated streptozotocin-induced diabetes in ratUmbreen Rashid0Muhammad Rashid Khan1Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam UniversityDepartment of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam UniversityAbstract Background Periploca aphylla is used by local population and indigenous medicine practitioners as stomachic, tonic, antitumor, antiulcer, and for treatment of inflammatory disorders. The aim of this study was to evaluate antidiabetic effect of the extract of P. aphylla and to investigate antioxidant and hypolipidemic activity in streptozotocin (STZ)-induced diabetic rats. Methods The present research was conducted to evaluate the antihyperglycemic potential of methanol extract of P. aphylla (PAM) and subfractions n-hexane (PAH), chloroform (PAC), ethyl acetate (PAE), n-butanol (PAB), and aqueous (PAA) in glucose-overloaded hyperglycemic Sprague-Dawley rats. Based on the efficacy, PAB (200 mg/kg and 400 mg/kg) was tested for its antidiabetic activity in STZ-induced diabetic rats. Diabetes was induced via intraperitoneal injection of STZ (55 mg/kg) in rat. Blood glucose values were taken weekly. HPLC-DAD analysis of PAB was carried out for the presence of various polyphenols. Results HPLC-DAD analysis of PAB recorded the presence of rutin, catechin, caffeic acid, and myricetin. Oral administration of PAB at doses of 200 and 400 mg/kg for 21 days significantly restored (P < 0.01) body weight (%) and relative liver and relative kidney weight of diabetic rats. Diabetic control rats showed significant elevation (P < 0.01) of AST, ALT, ALP, LDH, total cholesterol, triglycerides, LDL, creatinine, total bilirubin, and BUN while reduced (P < 0.01) level of glucose, total protein, albumin, insulin, and HDL in serum. Count of blood cells and hematological parameters were altered in diabetic rats. Further, glutathione peroxidase, catalase, superoxide dismutase, glutathione reductase, and total soluble protein concentration decreased while concentration of thiobarbituric acid reactive substances and percent DNA damages increased (P < 0.01) in liver and renal tissues of diabetic rats. Histopathological damage scores increased in liver and kidney tissues of diabetic rats. Intake of PAB (400 mg/kg) resulted in significant improvement (P < 0.01) of above parameters, and results were comparable to that of standard drug glibenclamide. Conclusion The result suggests the antihyperglycemic, antioxidant, and anti-inflammatory activities of PAB treatment in STZ-compelled diabetic rat. PAB might be used as new therapeutic agent in diabetic patients to manage diabetes and decrease the complications.https://doi.org/10.1186/s12199-021-00962-0AntidiabeticAntioxidantAnti-inflammatoryInsulinLipid profile
spellingShingle Umbreen Rashid
Muhammad Rashid Khan
Phytochemicals of Periploca aphylla Dcne. ameliorated streptozotocin-induced diabetes in rat
Environmental Health and Preventive Medicine
Antidiabetic
Antioxidant
Anti-inflammatory
Insulin
Lipid profile
title Phytochemicals of Periploca aphylla Dcne. ameliorated streptozotocin-induced diabetes in rat
title_full Phytochemicals of Periploca aphylla Dcne. ameliorated streptozotocin-induced diabetes in rat
title_fullStr Phytochemicals of Periploca aphylla Dcne. ameliorated streptozotocin-induced diabetes in rat
title_full_unstemmed Phytochemicals of Periploca aphylla Dcne. ameliorated streptozotocin-induced diabetes in rat
title_short Phytochemicals of Periploca aphylla Dcne. ameliorated streptozotocin-induced diabetes in rat
title_sort phytochemicals of periploca aphylla dcne ameliorated streptozotocin induced diabetes in rat
topic Antidiabetic
Antioxidant
Anti-inflammatory
Insulin
Lipid profile
url https://doi.org/10.1186/s12199-021-00962-0
work_keys_str_mv AT umbreenrashid phytochemicalsofperiplocaaphylladcneamelioratedstreptozotocininduceddiabetesinrat
AT muhammadrashidkhan phytochemicalsofperiplocaaphylladcneamelioratedstreptozotocininduceddiabetesinrat